Alza Overview
- Founded
-
1968

- Status
-
Acquired/Merged
- Employees
-
2,442

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$12.3B
Alza General Information
Description
Manufacturer of drug delivery systems created to develop pharmaceutical products with enhanced therapeutic value. The company's drug delivery systems include therapeutic devices for oral, transdermal, implantable and liposomal technologies, enabling healthcare sector to innovate and create novel medicines for the cure of chronic and life-threatening diseases.
Contact Information
Primary Office
- 1900 Charleston Road
- P.O. Box 7210
- Mountain View, CA 94039
- United States
Alza Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 22-Jun-2001 | $12.3B | 000.00 | Completed | Profitable | |
3. Merger/Acquisition | 17-Dec-1999 | 00.00 | 00.00 | Cancelled | Profitable | |
2. IPO | 08-Jun-1983 | Completed | Generating Revenue | |||
1. Early Stage VC | Completed | Startup |
Alza Patents
Alza Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2873425-A1 | Self-test for analgesic product | Inactive | 21-May-2012 | 000000000 | |
US-9095706-B2 | Self-test for analgesic product | Active | 21-May-2012 | 000000000 | |
US-20150338445-A1 | Self-test for analgesic product | Active | 21-May-2012 | 000000000 | |
US-20130310729-A1 | Self-test for analgesic product | Active | 21-May-2012 | 000000000 | |
AU-2013266914-B2 | Self-test for analgesic product | Inactive | 21-May-2012 | A61N1/303 |
Alza Signals
Alza Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Glynn Capital | Venture Capital | Minority | 000 0000 | 000000 0 |